GA
XENT

Geneva Advisors’s Intersect ENT, Inc XENT Stock Holding History

Geneva Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,747
Closed -$394K – 756
2016
Q1 		$394K Sell
20,747
-905
-4% -$16.4K 0.01% 483
2015
Q4 		$487K Sell
21,652
-5,283
-20% -$104K 0.01% 419
2015
Q3 		$630K Buy
26,935
+10,711
+66% +$296K 0.01% 355
2015
Q2 		$464K Buy
+16,224
New +$425K 0.01% 437

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geneva Advisors's XENT Position: Q2 2016 in Review

Geneva Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2016, closing a stake of 20,747 shares — an estimated $394K sold.

Geneva Advisors first reported a position in XENT in Q2 2015 and held it in 4 quarters. The position peaked at $630K in Q3 2015. 100 funds tracked by Wall St. Rank hold XENT as of Q2 2016.

  • Geneva Advisors reported no remaining Intersect ENT, Inc position as of Q2 2016 after selling out during the quarter.
  • Geneva Advisors sold 20,747 Intersect ENT, Inc shares in Q2 2016, an estimated $394K.
  • Geneva Advisors first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 4 quarters.
  • Geneva Advisors's Intersect ENT, Inc position peaked at $630K in Q3 2015.
  • 100 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2016.

Based on Geneva Advisors's 13F filing for Q2 2016, filed 8 Aug 2016.